FDA Makes Alzheimers Drug Leqembi Widely Accessible

The F.D.A. gave full approval to the drug, but added a black-box warning about safety risks. Medicare said it would cover most of the high cost.

source https://www.nytimes.com/2023/07/06/health/alzheimers-leqembi-medicare.html